Evaluation of the mass measles vaccination campaign in Guangdong Province, China

Int J Infect Dis. 2012 Feb;16(2):e99-103. doi: 10.1016/j.ijid.2011.09.023. Epub 2011 Nov 26.

Abstract

Objective: To evaluate the mass measles vaccination campaign of 2009 in Guangdong Province, China.

Methods: Data on the campaign implementation, measles surveillance, and serological surveillance were reviewed and analyzed by statistical methods.

Results: Rapid coverage surveys showed that 98.09% of children were vaccinated during the campaign. The coverage of migrant children increased significantly from 67.10% to 97.32% (p<0.01). From May to December 2009, after the campaign, the number of measles cases was reduced by 93.04% compared with the same period of 2008. The antibody positive rate in children aged less than 15 years reached above 95%. More than 1 million migrant children were identified and vaccinated during the campaign. Flyers, notices of information from doctors, and television programs were the best methods to inform parents of the campaign. Awareness of the campaign by residents increased significantly from 91.86% to 97.10% (p<0.01) through the use of social mobilization materials.

Conclusions: A massive vaccination campaign approach for controlling measles in a developing region like Guangdong Province with a vast migrant population has proved effective. Comprehensive mobilization, communication with the mass media, and support from government departments were critical to the success of the campaign.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • China
  • Female
  • Humans
  • Immunization Programs / methods
  • Immunoglobulin G / immunology
  • Immunologic Surveillance / immunology
  • Infant
  • Male
  • Mass Vaccination / adverse effects
  • Mass Vaccination / methods
  • Measles / immunology
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage*
  • Measles Vaccine / adverse effects
  • Measles Vaccine / immunology
  • Vaccination / methods

Substances

  • Immunoglobulin G
  • Measles Vaccine